Switch theme
Sign up to access all valuation multiples
Bluemtec Co Ltd is a company whose main business is selling prescription drugs through an e-commerce platform. It operates two pharmaceutical distribution platforms, BluePharmKorea targeting hospitals and clinics, and KoolPharm targeting pharmacies and provide IT services to operate and advance these two platforms. In addition, it is operating BlueLabs, which provides services and website development for pharmaceutical companies and medical institutions.
2015
n/a
LTM Revenue n/a
LTM EBITDA n/a
$106M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
BlueMTec has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, BlueMTec achieved revenue of $90.8M and an EBITDA of -$0.5M.
BlueMTec expects next 12-month revenue of XXX and NTM EBITDA of XXX
See BlueMTec valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $77.6M | $90.8M | XXX | XXX | XXX |
| Gross Profit | $8.9M | $9.7M | XXX | XXX | XXX |
| Gross Margin | 11% | 11% | XXX | XXX | XXX |
| EBITDA | -$1.0M | -$0.5M | XXX | XXX | XXX |
| EBITDA Margin | -1% | 0% | XXX | XXX | XXX |
| Net Profit | -$9.7M | -$1.6M | XXX | XXX | XXX |
| Net Margin | -13% | -2% | XXX | XXX | XXX |
| Net Debt | $2.0M | $1.4M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, BlueMTec's stock price is KRW 11530 (or $8).
BlueMTec has current market cap of KRW 129B (or $87.8M), and EV of KRW 155B (or $106M).
See BlueMTec trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $106M | $87.8M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, BlueMTec has market cap of $87.8M and EV of $106M.
BlueMTec's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate BlueMTec's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for BlueMTec and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $106M | XXX | XXX | XXX |
| EV/Revenue | 1.2x | XXX | XXX | XXX |
| EV/EBITDA | -234.1x | XXX | XXX | XXX |
| P/E | -26.8x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -10.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpBlueMTec's NTM/LTM revenue growth is n/a
BlueMTec's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, BlueMTec's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate BlueMTec's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for BlueMTec and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 17% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 0% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -55% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 6% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 15% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| MedPlus India | XXX | XXX | XXX | XXX | XXX | XXX |
| Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
| Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
| Redcare Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| Oriola | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
BlueMTec acquired XXX companies to date.
Last acquisition by BlueMTec was XXXXXXXX, XXXXX XXXXX XXXXXX . BlueMTec acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was BlueMTec founded? | BlueMTec was founded in 2015. |
| Where is BlueMTec headquartered? | BlueMTec is headquartered in South Korea. |
| Is BlueMTec publicy listed? | Yes, BlueMTec is a public company listed on KRX. |
| What is the stock symbol of BlueMTec? | BlueMTec trades under 439580 ticker. |
| When did BlueMTec go public? | BlueMTec went public in 2023. |
| Who are competitors of BlueMTec? | Similar companies to BlueMTec include e.g. MedPlus India, Pague Menos, Droga Raia, Redcare Pharmacy. |
| What is the current market cap of BlueMTec? | BlueMTec's current market cap is $87.8M |
| What is the current revenue growth of BlueMTec? | BlueMTec revenue growth between 2023 and 2024 was 17%. |
| Is BlueMTec profitable? | Yes, BlueMTec is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
